Bispecific antibodies stand as one of the most innovative and rapidly advancing frontiers in biopharmaceutical science. These are not ordinary antibodies; they are meticulously engineered molecules designed with a unique dual-targeting capability, allowing them to bind to two different antigens simultaneously. A prominent and powerful subset of this class is the Bispecific T-cell Engager...